The committee members voted unanimously to encourage to improve testing and increased research on epidemiology and treatment.
———-
Report of the Other Tick-Borne Diseases and Coinfections Subcommittee to the Tick-Borne Disease Working Group
Background: Why other tick-borne diseases and co-infections are important
Co-infection of ticks with human and animal pathogens is more widespread than is commonly recognized by both medical professionals and the public. Ticks contain multiple tick-borne pathogens, which can be transmitted with a single tick bite. Some tick-borne pathogens can be transmitted within a short period of time after a tick bite (i.e., Borrelia hermsii and Powassan virus), although other tick-borne pathogens such as Anaplasma, Ehrlichia, Babesia,Rickettsia and other borrelia species take longer. Transmission for some tick-borne diseases is also possible by blood transfusion (Babesia, Anaplasma, Bartonella, tick-borne relapsing fever), solid organ transplantation (Babesia), and through maternal-fetal transmission (Babesia, Bartonella, relapsing fever borreliae, certain arthropod borne flaviviruses). Increased awareness with appropriate testing and treatment is therefore important to help decrease morbidity and mortality from other tick-borne diseases and co-infections.
Current microbiologic science suggests that some tick-borne pathogens and co-infections can infect humans both acutely and chronically. These pathogens can persist in an indolent manner and reactivate periodically causing relapsing and remitting illness. Clinical observation of health care providers who see tick-borne disease patients observe that in persistently symptomatic patients more than one tick-borne disease is often present. It should be kept in mind that these co-infections may have been acquired sequentially, not necessarily with one single tick bite. Peer reviewed literature suggest coinfection of a patient with Babesia and Borrelia or with Ehrlichia, Anaplasma, and Borrelia result in increased symptoms and a longer duration of illness. The burden of borreliosis alone is documented, and society suffers in terms of lost productivity and patients requiring more care and support. Given that preliminary peer-reviewed data and clinical expert opinion notes increased morbidity when a patient has more than one tick-borne infection, the burden of coinfection is likely higher than that of borreliosis alone. Identifying the incidence of coinfection among chronically ill patients, while establishing effective diagnostic and treatment regimens, will help decrease the burden of illness and associated suffering.
https://www.hhs.gov/ash/advisory-committees/tickbornedisease/reports/other-tbds-2018-5-9/index.html#.Wvp355hLKlc.facebook
Report of the Other Tick-Borne Diseases and Coinfections Subcommittee to the Tick-Borne Disease Working Group
Background: Why other tick-borne diseases and co-infections are important
Co-infection of ticks with human and animal pathogens is more widespread than is commonly recognized by both medical professionals and the public. Ticks contain multiple tick-borne pathogens, which can be transmitted with a single tick bite. Some tick-borne pathogens can be transmitted within a short period of time after a tick bite (i.e., Borrelia hermsii and Powassan virus), although other tick-borne pathogens such as Anaplasma, Ehrlichia, Babesia,Rickettsia and other borrelia species take longer. Transmission for some tick-borne diseases is also possible by blood transfusion (Babesia, Anaplasma, Bartonella, tick-borne relapsing fever), solid organ transplantation (Babesia), and through maternal-fetal transmission (Babesia, Bartonella, relapsing fever borreliae, certain arthropod borne flaviviruses). Increased awareness with appropriate testing and treatment is therefore important to help decrease morbidity and mortality from other tick-borne diseases and co-infections.
Current microbiologic science suggests that some tick-borne pathogens and co-infections can infect humans both acutely and chronically. These pathogens can persist in an indolent manner and reactivate periodically causing relapsing and remitting illness. Clinical observation of health care providers who see tick-borne disease patients observe that in persistently symptomatic patients more than one tick-borne disease is often present. It should be kept in mind that these co-infections may have been acquired sequentially, not necessarily with one single tick bite. Peer reviewed literature suggest coinfection of a patient with Babesia and Borrelia or with Ehrlichia, Anaplasma, and Borrelia result in increased symptoms and a longer duration of illness. The burden of borreliosis alone is documented, and society suffers in terms of lost productivity and patients requiring more care and support. Given that preliminary peer-reviewed data and clinical expert opinion notes increased morbidity when a patient has more than one tick-borne infection, the burden of coinfection is likely higher than that of borreliosis alone. Identifying the incidence of coinfection among chronically ill patients, while establishing effective diagnostic and treatment regimens, will help decrease the burden of illness and associated suffering.
https://www.hhs.gov/ash/advisory-committees/tickbornedisease/reports/other-tbds-2018-5-9/index.html#.Wvp355hLKlc.facebook
hhs.gov
Report of the Other TBDS and Co-Infections Subcommittee to the TBDWG to consider for the Report to Congress
———-
Report of the Other Tick-Borne Diseases and Coinfections Subcommittee to the Tick-Borne Disease Working Group
Background: Why other tick-borne diseases and co-infections are important
Co-infection of ticks with human and animal pathogens is more widespread than is commonly recognized by both medical professionals and the public. Ticks contain multiple tick-borne pathogens, which can be transmitted with a single tick bite. Some tick-borne pathogens can be transmitted within a short period of time after a tick bite (i.e., Borrelia hermsii and Powassan virus), although other tick-borne pathogens such as Anaplasma, Ehrlichia, Babesia,Rickettsia and other borrelia species take longer. Transmission for some tick-borne diseases is also possible by blood transfusion (Babesia, Anaplasma, Bartonella, tick-borne relapsing fever), solid organ transplantation (Babesia), and through maternal-fetal transmission (Babesia, Bartonella, relapsing fever borreliae, certain arthropod borne flaviviruses). Increased awareness with appropriate testing and treatment is therefore important to help decrease morbidity and mortality from other tick-borne diseases and co-infections.
Current microbiologic science suggests that some tick-borne pathogens and co-infections can infect humans both acutely and chronically. These pathogens can persist in an indolent manner and reactivate periodically causing relapsing and remitting illness. Clinical observation of health care providers who see tick-borne disease patients observe that in persistently symptomatic patients more than one tick-borne disease is often present. It should be kept in mind that these co-infections may have been acquired sequentially, not necessarily with one single tick bite. Peer reviewed literature suggest coinfection of a patient with Babesia and Borrelia or with Ehrlichia, Anaplasma, and Borrelia result in increased symptoms and a longer duration of illness. The burden of borreliosis alone is documented, and society suffers in terms of lost productivity and patients requiring more care and support. Given that preliminary peer-reviewed data and clinical expert opinion notes increased morbidity when a patient has more than one tick-borne infection, the burden of coinfection is likely higher than that of borreliosis alone. Identifying the incidence of coinfection among chronically ill patients, while establishing effective diagnostic and treatment regimens, will help decrease the burden of illness and associated suffering.
https://www.hhs.gov/…/repor…/other-tbds-2018-5-9/index.html…
Report of the Other Tick-Borne Diseases and Coinfections Subcommittee to the Tick-Borne Disease Working Group
Background: Why other tick-borne diseases and co-infections are important
Co-infection of ticks with human and animal pathogens is more widespread than is commonly recognized by both medical professionals and the public. Ticks contain multiple tick-borne pathogens, which can be transmitted with a single tick bite. Some tick-borne pathogens can be transmitted within a short period of time after a tick bite (i.e., Borrelia hermsii and Powassan virus), although other tick-borne pathogens such as Anaplasma, Ehrlichia, Babesia,Rickettsia and other borrelia species take longer. Transmission for some tick-borne diseases is also possible by blood transfusion (Babesia, Anaplasma, Bartonella, tick-borne relapsing fever), solid organ transplantation (Babesia), and through maternal-fetal transmission (Babesia, Bartonella, relapsing fever borreliae, certain arthropod borne flaviviruses). Increased awareness with appropriate testing and treatment is therefore important to help decrease morbidity and mortality from other tick-borne diseases and co-infections.
Current microbiologic science suggests that some tick-borne pathogens and co-infections can infect humans both acutely and chronically. These pathogens can persist in an indolent manner and reactivate periodically causing relapsing and remitting illness. Clinical observation of health care providers who see tick-borne disease patients observe that in persistently symptomatic patients more than one tick-borne disease is often present. It should be kept in mind that these co-infections may have been acquired sequentially, not necessarily with one single tick bite. Peer reviewed literature suggest coinfection of a patient with Babesia and Borrelia or with Ehrlichia, Anaplasma, and Borrelia result in increased symptoms and a longer duration of illness. The burden of borreliosis alone is documented, and society suffers in terms of lost productivity and patients requiring more care and support. Given that preliminary peer-reviewed data and clinical expert opinion notes increased morbidity when a patient has more than one tick-borne infection, the burden of coinfection is likely higher than that of borreliosis alone. Identifying the incidence of coinfection among chronically ill patients, while establishing effective diagnostic and treatment regimens, will help decrease the burden of illness and associated suffering.
https://www.hhs.gov/…/repor…/other-tbds-2018-5-9/index.html…
hhs.gov
Report of the Other TBDS and Co-Infections Subcommittee to the TBDWG to consider for the Report to Congress
